| EPE244 | Use of generic ritonavir-boosted darunavir and dolutegravir for second line antiretroviral therapy is cost-effective in Zambia: a 10-year modelling analysis | E-poster | Costing of HIV, hepatitis and STI services |
| EPE245 | Cost of caregiver-assisted oral HIV screening of children in Uganda and Zambia | E-poster | Costing of HIV, hepatitis and STI services |
| EPE246 | Costs of pharmacy, workplace and hotspot HIV self-testing in Kenya | E-poster | Costing of HIV, hepatitis and STI services |
| EPE247 | Financial cost of a PrEP program among adolescent men who have sex with men and transgender women in Brazil | E-poster | Costing of HIV, hepatitis and STI services |
| PESUE23 | Do differentiated models of care for HIV treatment result in lower costs for recipients of care in Zambia? | Poster exhibition | Costing of HIV, hepatitis and STI services |
| EPA020 | Penile barrier integrity and a mechanistic search for the effectiveness of medical male circumcision in preventing HIV acquisition | E-poster | Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) |
| EPLBA07 | Host genetic variants regulates CCR5 expression on immune cells: a study in people living with HIV and healthy controls | E-poster | Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) |
| OALBA0105 | Metabolomic and lipidomic correlates of time-to-HIV-rebound in viremic controllers treated with vesatolimod | Oral abstract session with live Q&A | Correlates of HIV susceptibility, and progression versus control (biomarkers and genetics) |
| EPD454 | Experiences of intersecting stigma among young people living with HIV in Uganda | E-poster | Confronting stigma: Lessons learned |
| EPD455 | Digital storytelling to address stigma and discrimination in Uganda | E-poster | Confronting stigma: Lessons learned |